{"id": "1369730458909614081", "creation": 1615404164.0, "user_id": "370897496", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 1, "like_count": 6, "quote_count": 0}}, "text": "Congratulations to #NOVAVAX, Inc. Their #COVID19 #vaccine candidate demonstrated 89.3% efficacy in their pivotal #UK #Phase 3 #trial, including 96% against to the original COVID-19 and 86% against the B117 variant. We are  proud to be working with them to support their study. https://t.co/VSg99ClGqE", "first_save": 1634559108.199414, "hashtags": ["#NOVAVAX", "#COVID19", "#VACCINE", "#UK", "#PHASE", "#TRIAL"]}